EVALUATION OF 25-HYDROXY VITAMIN D LEVELS IN PATIENTS TREATED FOR FIBROMYALGIA
Journal Title: Kocatepe Medical Journal - Year 2022, Vol 23, Issue 3
Abstract
OBJECTIVE: The aim of this study was to evaluate 25-hydroxy vitamin D (25(OH)D) levels in patients receiving fibromyalgia treatment. MATERIAL AND METHODS: In the study, the data of 244 patients aged 18 years and older who were diagnosed with fibromyalgia according to the ACR (American College of Rheumatologist) 2010 diagnostic criteria in our hospital between January 2018 and March 2020, and other systemic diseases were excluded, and the data of 120 patients as the control group were etrospectively reviewed. The patients who received fibromyalgia treatment and the patients in the control group were divided into three groups according to their serum 25-hydroxy vitamin D levels (deficient, insufficient and normal). It was analysed whether there was a statistically significant difference between the groups. In addition, vitamin D levels of the patient group were evaluated according to age ranges. P value less than 0.05 was considered as significant. RESULTS: Of the 244 patients diagnosed with fibromyalgia included in the study, 66.4% (n=162) were female and 33.6% (n=82) were male. The mean serum 25(OH)D level of the patient group was calculated as 16.2±12.7 ng/ml. Of the 120 patients taken as the control group, 70% (n=84) were female and 30% (n=36) were male. Mean serum 25(OH)D level of the control group was calculated as 24.6±13.1 ng/ml. When the gender and serum 25(OH)D levels of the patients in the fibromyalgia treatment group and the control group were compared statistically, a significant difference was found between the groups (p=0.017). In addition, we found the lowest serum 25 (OH) D level in the patient group between the ages of 36-50. CONCLUSIONS: High levels of vitamin D deficiency and insufficiency are observed in patients receiving fibromyalgia treatment. Therefore, adequate replacement in patients with low vitamin D levels will provide a significant decrease in musculoskeletal system symptoms and complaints.
Authors and Affiliations
Harun DÜĞEROĞLU
Keywords
Related Articles
- EP ID EP706867
- DOI https://doi.org/10.18229/kocatepetip.902645
- Views 73
- Downloads 0
EFFECT OF SUBCLINICAL HYPOTHYROIDISM ON BIOCHEMICAL PARAMETERS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
OBJECTIVE: Subclinical hypothyroidism is a biochemical definition with elevated TSH (thyroid stimulating hormone) levels while free thyroid hormone levels are normal. Type 2 DM (diabetes mellitus) patients frequently hav...
DIFFUSION WEIGHTED IMAGING OF SOFT TISSUE MASSES: CAN APPARENT DIFFUSION COEFFICIENT MEASUREMENT DIFFERENTIATE BETWEEN MALIGNANT AND BENIGN LESIONS ?
OBJECTIVE: To investigate the efficacy of apparent diffusion coefficient (ADC) mapping obtained using the diffusion-weighted imaging (DWI) method in the differentiation of benign and malignant lesions of soft tissue tumo...
CLINICOPATHOLOGICAL EVALUTION OF NATIVE KIDNEY BIOPSIES IN CHILDREN
OBJECTIVE: It is aimed to evaluate kidney biopsies, which is an important diagnostic method in the evaluation of renal parenchymal diseases. MATERIAL AND METHODS: In this study, native kidney biopsies performed on 333 p...
USAGE/UTILITY OF FLEXIBLE FIBEROPTIC BRONCHOSCOPY IN ADULT INTENSIVE CARE UNIT
OBJECTIVE: Flexible fiberoptic bronchoscopy (FOB) is a method widely used in the intensive care unit for both diagnosis and treatment. The aim of this study was to evaluate the indications of FOBs performed in the adult...
INVESTIGATION OF THE IMMUNOMODULATOR EFFECT OF BETA GLUCAN IN THE EXPERIMENTAL INTRAABDOMINAL BACTERIEMIA MODEL WITH STAPHYLOCOCCUS AUREUS
OBJECTIVE: The purpose of this study is to investigate the immunomodulatory effect of beta glucan in an experimental model of intraabdominal bacteremia induced by S. aureus. MATERIAL AND METHODS: Thirty Wistar albino ra...